ProShare Advisors
BVS icon

ProShare Advisors’s Bioventus BVS Stock Holding History

ProShare Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,798
Closed -$113K – 2110
2024
Q4 		$113K Buy
+10,798
New +$128K ﹤0.01% 2051
2022
Q2 		– Sell
-11,406
Closed -$162K – 1830
2022
Q1 		$162K Sell
11,406
-3,087
-21% -$41.3K ﹤0.01% 1934
2021
Q4 		$211K Buy
+14,493
New +$206K ﹤0.01% 1994

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ProShare Advisors's BVS Position: Q1 2025 in Review

ProShare Advisors sold out of Bioventus (BVS) in Q1 2025, closing a stake of 10,798 shares — an estimated $113K sold.

ProShare Advisors first reported a position in BVS in Q4 2021 and held it in 3 quarters. The position peaked at $211K in Q4 2021. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • ProShare Advisors reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • ProShare Advisors sold 10,798 Bioventus shares in Q1 2025, an estimated $113K.
  • ProShare Advisors first reported a position in Bioventus in Q4 2021 and held it in 3 quarters.
  • ProShare Advisors's Bioventus position peaked at $211K in Q4 2021.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on ProShare Advisors's 13F filing for Q1 2025, filed 8 May 2025.